Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer (Q43713973)

26 November 2017

title

Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer (English)

1 reference

26 November 2017

Jian Dong Wang

1

1 reference

26 November 2017

Wei Bin Shi

2

1 reference

26 November 2017

Jun Shen

3

1 reference

26 November 2017

Peng Yuan Zhuang

4

1 reference

26 November 2017

Zhi Wei Quan

5

1 reference

26 November 2017

Xue Feng Wang

6

1 reference

26 November 2017

Xue Ping Zhou

7

1 reference

26 November 2017

Song Gang Li

8

1 reference

26 November 2017

Ying Bin Liu

9

1 reference

26 November 2017

Yong Yang

10

1 reference

26 November 2017

publication date

7 December 2010

1 reference

26 November 2017

1 reference

26 November 2017

volume

28 Suppl 1

1 reference

26 November 2017

page(s)

S295-300

1 reference

Epidemiology and molecular pathology of gallbladder cancer

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Nonsurgical management of gallbladder cancer: cytotoxic treatment and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

21 January 2018

1 reference

12 December 2020

Chemotherapy for gallbladder carcinoma--a surgeon's perspective

1 reference

12 December 2020

Comparison of time trends in gallbladder cancer incidence (1973-1997) in East Asia, Europe and the USA, from Cancer Incidence in Five Continents Vols IV-VIII

1 reference

12 December 2020

1 reference

12 December 2020

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

1 reference

12 December 2020

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours

1 reference

12 December 2020

10.1007/S12032-010-9758-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1021638850

0 references

1 reference